ThirdWaveRx manages pharmaceutical rebates with PBM relationships and eligibility reviews.
ThirdWaveRx has raised $19.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2022.
ThirdWaveRx's investors include WindRose Health Investors, MFO Ventures.
ThirdWaveRx is headquartered in Las Vegas, United States.
ThirdWaveRx manages pharmaceutical rebates with PBM relationships and eligibility reviews.
ThirdWaveRx is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ThirdWaveRx — Funding & Investors." VCBacked, October 4, 2022, https://www.vcbacked.co/company/thirdwaverx. Accessed September 30, 2026.
VCBacked. (2022). ThirdWaveRx — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/thirdwaverx
{{cite web |title=ThirdWaveRx — Funding & Investors |url=https://www.vcbacked.co/company/thirdwaverx |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated